Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: Risk of Nocturnal Hypoglycemia and Arrhythmias With Sitagliptin Versus Glimepiride in Patients With Type 2 Diabetes [Phase 4]
Phase 4 trial comparing risk of nocturnal hypoglycemia and arrhythmias between sitagliptin and glimepiride in type 2 diabetes; terminated wi…
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Lipid Biomarkers for Diabetic Heart Disease [NA]
A completed clinical trial studying lipid biomarkers in diabetic heart disease; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: A Randomized Controlled Trial Evaluating One Drop | Premium With Afrezza vs. One Drop | Premium Alone [Phase 4]
A Phase 4 randomized trial comparing One Drop Premium with Afrezza vs One Drop Premium alone in adults with Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2019-02-25Clinical Trial Update: Randomized Sitagliptin Withdrawal Study (MK-0431-845) [Phase 3]
A Phase 3 randomized withdrawal study of sitagliptin (MK-0431-845) in adults with type 2 diabetes mellitus has completed, with results poste…
-
CLINICAL_TRIALS trial_result · 2019-02-25Clinical Trial Update: A Dose-Finding, Efficacy and Safety Study of YY-351 in Patients With Type 2 Diabetes [Phase 2]
A Phase 2 dose-finding study evaluated YY-351 for efficacy and safety in patients with type 2 diabetes.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-02-25Clinical Trial Update: Study of the QOL Evaluation of Trelagliptin in Patients With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 clinical trial updating quality of life evaluation for Trelagliptin in adults with type 2 diabetes; results posted after completion.
-
FDA approval · 2019-02-22FDA Approved: PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Pioglitazone hydrochloride and metformin hydrochloride (Aurobindo Pharma Limited), a generic com…
-
FDA approval · 2019-02-22FDA Approved: METFORMIN HCL — Supplemental Application (TIME CAP LABORATORIES, INC)
The FDA approved a supplemental application for METFORMIN HCL by Time Cap Laboratories, Inc., under ANDA 090888. The product is a generic me…
-
FDA approval · 2019-02-22FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Westminster Pharmaceuticals, LLC)
FDA approved a supplemental application for Metformin Hydrochloride (generic) submitted by Westminster Pharmaceuticals, LLC.
-
FDA approval · 2019-02-22FDA Approved: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Dapagliflozin and Metformin Hydrochloride, a fixed-dose combination product from Prasco Laborato…
-
FDA approval · 2019-02-22FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
The FDA approved Granules Pharmaceuticals Inc.'s supplemental application for METFORMIN HYDROCHLORIDE, indicating an approved modification t…
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Teneligliptin Versus Linagliptin in Diabetes Mellitus Type Two Patients [Phase 4]
Phase 4 trial comparing Teneligliptin to Linagliptin in patients with Type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Study of FibroGen (FG)-3019 in Subjects With Type 2 Diabetes Mellitus and Kidney Disease on ACEi and/or ARB Therapy [Phase 2]
A Phase 2 study of pamrevlumab (FG-3019) in subjects with type 2 diabetes mellitus and diabetic kidney disease on ACE inhibitors or ARBs has…
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-387 Under Fed Condition [Phase 1]
A Phase 1 trial evaluating the pharmacokinetics and safety/tolerability of CKD-387 under fed conditions in Type 2 diabetes mellitus; the stu…
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 Under Fed Condition [Phase 1]
Phase 1 study update reports pharmacokinetics and safety/tolerability of oral CKD-387 and D635 under fed conditions in individuals with Type…
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults [Phase 1]
Phase 1 trial assessing pharmacokinetics and safety/tolerability after oral dosing of two investigational compounds, CKD-387 and D635, in he…
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: Bioequivalence Study of Empagliflozin Tablet in Healthy Participants. [NA]
This clinical trial update reports the completion of a bioequivalence study of empagliflozin tablets in healthy participants.
-
EMA withdrawal · 2019-02-20EMA Withdrawn: Eperzan (albiglutide) — GlaxoSmithKline Trading Services Limited
The EMA has withdrawn Eperzan (albiglutide) from the European market.
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: Effects of Ketone Bodies on Cognition in Type 2 Diabetes [Phase 1]
A Phase 1 clinical trial evaluated whether ketone bodies affect cognitive function in individuals with Type 2 diabetes; the study has comple…
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: Development of Pre-pregnancy Intervention to Reduce the Risk of Diabetes and Prediabetes [Phase 4]
Phase 4 clinical trial update from Novo Nordisk indicates completion of a pre-pregnancy intervention study aimed at reducing the risk of typ…
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: Sitagliptin and Glucagon Counterregulation [Phase 4]
Phase 4 clinical trial update evaluating sitagliptin's effect on glucagon counterregulation in adults with type 2 diabetes; results have bee…
-
CLINICAL_TRIALS trial_result · 2019-02-18Clinical Trial Update: Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009) [Phase 1]
This Phase 1 trial evaluated how renal impairment influences the pharmacokinetics, pharmacodynamics, safety, and tolerability of ertuglifloz…
-
CLINICAL_TRIALS trial_result · 2019-02-18Clinical Trial Update: Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Insulin Products / Long-term Treatment"
A completed clinical trial investigating the combined use of pioglitazone tablets with insulin products for long-term treatment of type 2 di…
-
CLINICAL_TRIALS trial_result · 2019-02-18Clinical Trial Update: High-fat Overfeeding, Hepatokines and Appetite Regulation [NA]
A completed clinical trial from Loughborough University investigates how high-fat overfeeding affects hepatokines and appetite regulation in…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Empagliflozin Add on to Linagliptin Study in Japanese Patient With Type 2 Diabetes Mellitus [Phase 3]
A Phase 3 trial evaluating empagliflozin added to linagliptin in Japanese adults with type 2 diabetes has completed and posted results.